跳至主要内容
临床试验/NCT01245738
NCT01245738
已完成
不适用

Dyslipidemia: REsidual and Mixed Abnormalities IN Spite of Statin Therapy: The Dyslipidemia REMAINS Study: A Multicenter, Prospective, Observational Study of Lipid Profiles and Treatment Patterns at Presentation and After 12 Weeks of Statin Therapy Among Indian Adults Presenting With First Coronary Event

Merck Sharp & Dohme LLC0 个研究点目标入组 635 人2010年8月

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Dyslipidemias
发起方
Merck Sharp & Dohme LLC
入组人数
635
主要终点
Total Cholesterol (TC) Levels at First Acute Coronary Event
状态
已完成
最后更新
9年前

概览

简要总结

The current study is proposed to investigate the pattern of dyslipidemia and of lipid treatment practices in patients in India experiencing their first acute cardiovascular event and the extent of residual dyslipidemia after 12 weeks of treatment with statins. Dyslipidemia definitions are per the National Cholesterol Education Program - Adult Treatment Panel III (NCEP-ATP III).

注册库
clinicaltrials.gov
开始日期
2010年8月
结束日期
2012年12月
最后更新
9年前
研究类型
Observational
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • Currently admitted with a confirmed diagnosis of first acute coronary event (STEMI/NSTEMI/Unstable Angina)
  • Access to medical records covering the entire study period, and availability of data required for the study
  • Potential to collect blood sample within 24 hours of onset for symptoms
  • Considered for initiation/maintenance/modification of statin therapy before discharge from hospital
  • Willing to comply with the study requirements

排除标准

  • Participating in a clinical trial or any type of other clinical study involving therapeutic intervention or otherwise failing to consent to interview
  • Known inherited disorder of lipoprotein metabolism
  • History of hypothyroidism, nephrotic syndrome, chronic alcoholism, Cushing syndrome

结局指标

主要结局

Total Cholesterol (TC) Levels at First Acute Coronary Event

时间窗: At hospital presentation (Day 1)

At the time of hospital admission for a first acute coronary event, the TC levels of eligible participants were taken. This level was considered the baseline value. A TC level of \>240 mg/dL is considered an abnormal lipid value (dyslipidemia).

Low-Density Lipoprotein Cholesterol (LDL-C) Levels at First Acute Coronary Event

时间窗: At hospital presentation (Day 1)

At the time of hospital admission for a first acute coronary event, the LDL-C levels of eligible participants were taken. This level was considered the baseline value. A LDL-C level of \>70 mg/dL is considered an abnormal lipid value (dyslipidemia).

High-Density Lipoprotein Cholesterol (HDL-C) Levels at First Acute Coronary Event

时间窗: At hospital presentation (Day 1)

At the time of hospital admission for a first acute coronary event, the HDL-C levels of eligible participants were taken. This level was considered the baseline value. A HDL-C level of \<40 mg/dL is considered an abnormal lipid value (dyslipidemia).

Triglycerides (TG) Levels at First Acute Coronary Event

时间窗: At hospital presentation (Day 1)

At the time of hospital admission for a first acute coronary event, the TG levels of eligible participants were taken. This level was considered the baseline value. A TG level of \>150 mg/dL is considered an abnormal lipid value (dyslipidemia).

Change From Baseline in TC Levels After Treatment

时间窗: Baseline and at Week 12

TC levels were measured after 12 weeks of treatment with a statin. The change from baseline was calculated as the difference between baseline and Week 12 values.

Change From Baseline in LDL-C Levels After 12 Weeks of Treatment With Statins

时间窗: Baseline and at Week 12

LDL-C levels were measured after 12 weeks of treatment with a statin. The change from baseline was calculated as the difference between baseline and Week 12 values.

Change From Baseline in HDL-C Levels After 12 Weeks of Treatment With Statins

时间窗: Baseline and at Week 12

HDL-C levels were measured after 12 weeks of treatment with a statin. The change from baseline was calculated as the difference between baseline and Week 12 values.

Change From Baseline in TG Levels After 12 Weeks of Treatment With Statins

时间窗: Baseline and at Week 12

TG levels were measured after 12 weeks of treatment with a statin. The change from baseline was calculated as the difference between Baseline and Week 12 values.

Percentage of Participants Who Achieved Target Lipid Levels for LDL-C But Did Not Achieve Target Lipid Levels for HDL-C and TG After 12 Weeks of Treatment With Statins

时间窗: Week 12

The percentage of participants who achieved predefined lipid target levels after 12 weeks of treatment with statins. Predefined lipid target levels were: LDL-C less than 70 mg/dL, HDL-C greater than 40 mg/dL, and TG less than 150 mg/dL.

Percentage of Participants Who Achieved Target Lipid Levels for TG and LDL-C But Did Not Achieve Target Lipid Levels for HDL-C After 12 Weeks of Treatment With Statins

时间窗: Week 12

The percentage of participants who achieved predefined lipid target levels after 12 weeks of treatment with statins. Predefined lipid target levels were: LDL-C less than 70 mg/dL, HDL-C greater than 40 mg/dL, and TG less than 150 mg/dL.

Percentage of Participants Who Achieved Target Lipid Levels of HDL-C and LDL-C But Did Not Achieve Target Lipid Levels for TG After 12 Weeks of Treatment With Statins

时间窗: Week 12

The percentage of participants who achieved predefined lipid target levels after 12 weeks of treatment with statins. Predefined lipid target levels were: LDL-C less than 70 mg/dL, HDL-C greater than 40 mg/dL, and TG less than 150 mg/dL.

Percentage of Participants Who Did Not Achieve Target Lipid Levels for LDL-C, HDL-C, and TG After 12 Weeks of Treatment With Statins

时间窗: Week 12

The percentage of participants who achieved predefined lipid target levels after 12 weeks of treatment with statins. Predefined lipid target levels were: LDL-C less than 70 mg/dL, HDL-C greater than 40 mg/dL, and TG less than 150 mg/dL.

Percentage of Participants Who Achieved Target Lipid Levels for TG But Did Not Achieve Target Lipid Levels for HDL-C and LDL-C After 12 Weeks of Treatment With Statins

时间窗: Week 12

The percentage of participants who achieved predefined lipid target levels after 12 weeks of treatment with statins. Predefined lipid target levels were: LDL-C less than 70 mg/dL, HDL-C greater than 40 mg/dL, and TG less than 150 mg/dL.

Percentage of Participants Who Achieved Target Lipid Levels of HDL-C But Did Not Achieve Target Lipid Levels for TG and LDL-C After 12 Weeks of Treatment With Statins

时间窗: Week 12

The percentage of participants who achieved predefined lipid target levels after 12 weeks of treatment with statins. Predefined lipid target levels were: LDL-C less than 70 mg/dL, HDL-C greater than 40 mg/dL, and TG less than 150 mg/dL.

相似试验